Skip to content

A prospective study to evaluate the clinical significance of pancreatic elasticity measurement during chemotherapy for pancreatic cancer

A prospective study to evaluate the clinical significance of pancreatic elasticity measurement during chemotherapy for pancreatic cancer - A prospective study to evaluate the clinical significance of pancreatic elasticity measurement during chemotherapy for pancreatic cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000038763
Enrollment
40
Registered
2019-12-05
Start date
2019-12-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Sponsors

Nagoya University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients over 20 years old 2)Cases in which US or EUS was performed and the final diagnosis was pancreatic cancer 3)Written informed consent

Exclusion criteria

Exclusion criteria: 1)minors 2)Not written informed consent

Design outcomes

Primary

MeasureTime frame
Changes in pancreatic cancer stiffness

Secondary

MeasureTime frame
Characteristics Clinical findings Pathological findings

Countries

Japan

Contacts

Public ContactMasakatsu Yoshikawa

Nagoya University Graduate School of Medicine Department of gastroenterology

m-yoshi@med.nagoya-u.ac.jp052-744-2602

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026